tg-c
Cell therapyexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
2
Phase 4
0
Earliest trial started Sep 16, 2018 (NCT03291470)
Timeline
Indications
Mechanism of action
- Unspecified targetTissue restoration
tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06144970 | Phase 1 | Nov 1, 2025 | TissueGene, Inc. |
| NCT05276011 | Phase 2 | Oct 31, 2023 | TissueGene, Inc. |
| NCT03203330 | Phase 3 | Sep 16, 2018 | The Cleveland Clinic, TissueGene, Inc. |
| NCT03291470 | Phase 3 | Sep 16, 2018 | Commonwealth Orthopedics, TissueGene, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| TissueGene, Inc. | For profit | 4 | 4 | 3 | 2018 |
| Commonwealth Orthopedics | Academic/Hospital | 1 | 0 | 1 | 2018 |
| The Cleveland Clinic | Academic/Hospital | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1